University of Washington

Health Systems and Population Health

SCHOOL OF PUBLIC HEALTH

An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetes.


  1. Home


  2. An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetes.


  3. An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetes.

rakerr2

Ramsey SD, Clarke LD, Roberts CS, Sullivan SD, Johnson SJ, Liu LZ. An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetes. Pharmacoeconomics. 2008;26(4):329-39.

Upcoming Events

Full Calendar

News Categories